A roundup of scientific studies on the novel coronavirus and efforts to find treatments and vaccines includes research on Covid-19 patients who still have symptoms 6 months after falling ill.
AI Can Detect Covid-19 by Analyzing Coughs and More Related Research
ACE2 (angiotensin-converting enzyme-2), Antibodies, Artificial Intelligence, Blood Samples, Brigham and Women's Hospital, Cells, Children, Coronavirus Disease 2019 (COVID-19), Cough, Massachusetts Institute of Technology (MIT), Mouth, R&D, Researchers, RNA, Science Translational MedicineResearchers at Massachusetts Institute of Technology (MIT) developed an artificial intelligence (AI) model able to detect asymptomatic Covid-19 cases by identifying differences in the sounds of coughs between healthy and infected people.
Research Roundup: CovidD-19 Pain Relief and More
ACE2 (angiotensin-converting enzyme-2), Aerosols, Clinical Trials, Colorectal Cancer, Coronavirus, Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Ear Infections, Epithelial Cells, Immunity, Medical Journals, Neurons, Neuropilins, Pain, Pain Relief, Proteins, R&D, Research, SARS-CoV-2 spike protein, University of Arizona Health Sciences, University of Barcelona, University of Montana, University of Utah, Vascular Endothelial Growth Factor-A (VEGF-A) ProteinBioSpace reviews some of the more interesting recently published scientific studies, including whether the Covid-19 virus relieve pain.
iBio’s FastPharming Platform Produces Decoy Therapeutic to Bind to SARS-CoV-2
ACE2 (angiotensin-converting enzyme-2), Business, Immunoadhesin Molecules, Licensing, Product Pipeline, R&D, Recombinant Proteins, SARS-CoV-2 spike protein, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), TherapeuticsiBio Inc. is developing a decoy molecule as a therapeutic against SARS-CoV-2.
New Research Sheds Light on the Temporary Loss of Smell Stemming from Covid-19
ACE2 (angiotensin-converting enzyme-2), Clinical Trials, Coronavirus Disease 2019 (COVID-19), Electronic Health Records, Harvard Medical School, JAMA Otolaryngology Head and Neck Surgery, Medical Schools, Neuroscience, Olfactory Neurons, Proteins, R&D, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Smell, Symptoms: Coronavirus Disease 2019 (COVID-19), TasteAccording to a study published in the journal Science Advances, an international team of researchers led by neuroscientists at Harvard Medical School uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes Covid-19.
Mutated COVID-19 Viral Strain in U.S. and Europe 10 Times More Contagious than Original Strain
ACE2 (angiotensin-converting enzyme-2), Asia, Cells, Coronavirus Disease 2019 (COVID-19), Europe, Genetic Mutations, Institutes, Mutations, Proteins, R&D, Researchers, Scripps Research Institute, Studies, United StatesResearchers at the The Scripps Research Institute found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.
A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body.
Enzyme makes men more vulnerable to coronavirus; adding interferon may improve treatment
ACE2 (angiotensin-converting enzyme-2), Angiotensin Receptor Blockers (ARBs), Blood, Blood Pressure, Cells, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Enzymes, Europe, Hospitalizations, Pregnancies, Scientists, Studies, Sweden, The Lancet, United KingdomA brief roundup of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Coronavirus Transmission: Where the Virus Goes in the Body and How SARS-CoV-2 is Spread
ACE2 (angiotensin-converting enzyme-2), Coronavirus Disease 2019 (COVID-19), Coronavirus Infections, Dr. Anthony Fauci (Director), Human Body, Medical Journals, National Institute of Allergy and Infectious Diseases (NIAID), R&D, Researchers, Science, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), The Lancet, World Health OrganizationA look at which parts of the body the novel coronavirus infects and how SARS-CoV-2 is transmitted from person to person.
At least three different biotech companies are working on two ACE2-related drugs to find a solution to the COVID-19 pandemic.